[The results of testing in administration of a new sulfonylurea derivative (metzhexamide) in oral diabetes therapy].
D003920:Diabetes Mellitus; D006801:Humans; D007004:Hypoglycemic Agents / Q000628:therapy*; D013453:Sulfonylurea Compounds
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds
ANTIDIABETICS/therapy